

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.99439639 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.99439639 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.45113308 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 5.32864097 |
| 5 | intestinal absorption (GO:0050892) | 5.28812585 |
| 6 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.10751754 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.94973333 |
| 8 | desmosome organization (GO:0002934) | 4.90791506 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.84871536 |
| 10 | vitamin transmembrane transport (GO:0035461) | 4.71080269 |
| 11 | glucuronate metabolic process (GO:0019585) | 4.54721042 |
| 12 | uronic acid metabolic process (GO:0006063) | 4.54721042 |
| 13 | cellular glucuronidation (GO:0052695) | 4.44501109 |
| 14 | L-fucose catabolic process (GO:0042355) | 4.43791215 |
| 15 | fucose catabolic process (GO:0019317) | 4.43791215 |
| 16 | L-fucose metabolic process (GO:0042354) | 4.43791215 |
| 17 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.40869163 |
| 18 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.33811326 |
| 19 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.27481113 |
| 20 | intestinal epithelial cell development (GO:0060576) | 4.22663051 |
| 21 | flavonoid metabolic process (GO:0009812) | 4.17646394 |
| 22 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.16404623 |
| 23 | regulation of bile acid biosynthetic process (GO:0070857) | 4.06039354 |
| 24 | positive regulation of B cell differentiation (GO:0045579) | 3.99969816 |
| 25 | angiotensin maturation (GO:0002003) | 3.95955016 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.95111595 |
| 27 | kidney morphogenesis (GO:0060993) | 3.92009153 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.85170967 |
| 29 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.84254128 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.82044496 |
| 31 | homocysteine metabolic process (GO:0050667) | 3.79987127 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 3.72553234 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 3.72553234 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.72553234 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.72553234 |
| 36 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.72553234 |
| 37 | modulation by symbiont of host immune response (GO:0052553) | 3.72553234 |
| 38 | hepatocyte apoptotic process (GO:0097284) | 3.72361762 |
| 39 | O-glycan processing (GO:0016266) | 3.72350280 |
| 40 | arginine metabolic process (GO:0006525) | 3.69824128 |
| 41 | fucosylation (GO:0036065) | 3.69633925 |
| 42 | actin nucleation (GO:0045010) | 3.68853141 |
| 43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.68416268 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 3.64780628 |
| 45 | epoxygenase P450 pathway (GO:0019373) | 3.63125259 |
| 46 | drug catabolic process (GO:0042737) | 3.61563997 |
| 47 | exogenous drug catabolic process (GO:0042738) | 3.59010496 |
| 48 | gap junction assembly (GO:0016264) | 3.58322723 |
| 49 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.56819484 |
| 50 | primary alcohol catabolic process (GO:0034310) | 3.51350867 |
| 51 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.44474166 |
| 52 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.44276526 |
| 53 | response to type I interferon (GO:0034340) | 3.41151612 |
| 54 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.41103565 |
| 55 | regulation of B cell differentiation (GO:0045577) | 3.40533391 |
| 56 | positive regulation of interferon-alpha production (GO:0032727) | 3.40184268 |
| 57 | drug metabolic process (GO:0017144) | 3.40121410 |
| 58 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.37663659 |
| 59 | tolerance induction (GO:0002507) | 3.36390392 |
| 60 | type I interferon signaling pathway (GO:0060337) | 3.35748486 |
| 61 | cellular response to type I interferon (GO:0071357) | 3.35748486 |
| 62 | respiratory burst (GO:0045730) | 3.34068958 |
| 63 | bile acid and bile salt transport (GO:0015721) | 3.32425289 |
| 64 | plasma lipoprotein particle assembly (GO:0034377) | 3.32334350 |
| 65 | L-ascorbic acid metabolic process (GO:0019852) | 3.32184727 |
| 66 | sulfate transmembrane transport (GO:1902358) | 3.29709065 |
| 67 | sulfur compound transport (GO:0072348) | 3.29286451 |
| 68 | B cell receptor signaling pathway (GO:0050853) | 3.28990502 |
| 69 | regulation of interferon-alpha production (GO:0032647) | 3.27433479 |
| 70 | ethanol metabolic process (GO:0006067) | 3.22669870 |
| 71 | vitamin transport (GO:0051180) | 3.20751010 |
| 72 | positive regulation of respiratory burst (GO:0060267) | 3.19126275 |
| 73 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.18730791 |
| 74 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.18697645 |
| 75 | regulation of gene silencing by miRNA (GO:0060964) | 3.18697645 |
| 76 | regulation of gene silencing by RNA (GO:0060966) | 3.18697645 |
| 77 | sphingomyelin metabolic process (GO:0006684) | 3.17621961 |
| 78 | ethanol oxidation (GO:0006069) | 3.16789715 |
| 79 | T cell migration (GO:0072678) | 3.15387341 |
| 80 | transcytosis (GO:0045056) | 3.14824826 |
| 81 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.14428633 |
| 82 | myeloid dendritic cell activation (GO:0001773) | 3.13762661 |
| 83 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.12074449 |
| 84 | negative regulation of cell killing (GO:0031342) | 3.12074449 |
| 85 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.11505928 |
| 86 | leukocyte aggregation (GO:0070486) | 3.09481903 |
| 87 | vitamin A metabolic process (GO:0006776) | 3.09271011 |
| 88 | sulfate transport (GO:0008272) | 3.08929926 |
| 89 | response to interleukin-15 (GO:0070672) | 3.08306922 |
| 90 | high-density lipoprotein particle remodeling (GO:0034375) | 3.07135993 |
| 91 | phospholipid efflux (GO:0033700) | 3.06788310 |
| 92 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.05177812 |
| 93 | cellular extravasation (GO:0045123) | 3.03867707 |
| 94 | mast cell activation (GO:0045576) | 3.02817563 |
| 95 | neutrophil activation involved in immune response (GO:0002283) | 3.02060550 |
| 96 | antibacterial humoral response (GO:0019731) | 3.01984604 |
| 97 | hormone catabolic process (GO:0042447) | 3.01350535 |
| 98 | heme transport (GO:0015886) | 3.00281768 |
| 99 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.99947438 |
| 100 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.99512616 |
| 101 | myeloid dendritic cell differentiation (GO:0043011) | 2.99502242 |
| 102 | response to protozoan (GO:0001562) | 2.99230694 |
| 103 | tight junction assembly (GO:0070830) | 2.97249652 |
| 104 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.97238566 |
| 105 | auditory receptor cell differentiation (GO:0042491) | 2.97042980 |
| 106 | interferon-gamma production (GO:0032609) | 2.96836756 |
| 107 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.96737777 |
| 108 | regulation of cGMP biosynthetic process (GO:0030826) | 2.96267641 |
| 109 | negative regulation of phagocytosis (GO:0050765) | 2.95888464 |
| 110 | natural killer cell differentiation (GO:0001779) | 2.95730528 |
| 111 | regulation of keratinocyte proliferation (GO:0010837) | 2.94584173 |
| 112 | establishment of apical/basal cell polarity (GO:0035089) | 2.94461035 |
| 113 | bile acid metabolic process (GO:0008206) | 2.94207105 |
| 114 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.94120080 |
| 115 | mature B cell differentiation (GO:0002335) | 2.93687335 |
| 116 | protein autoprocessing (GO:0016540) | 2.93257003 |
| 117 | regulation of triglyceride catabolic process (GO:0010896) | 2.92121157 |
| 118 | transepithelial transport (GO:0070633) | 2.90961261 |
| 119 | regulation of T cell tolerance induction (GO:0002664) | 2.90293338 |
| 120 | axonemal dynein complex assembly (GO:0070286) | 2.89841883 |
| 121 | sulfation (GO:0051923) | 2.89504015 |
| 122 | B cell mediated immunity (GO:0019724) | 2.88742553 |
| 123 | glutathione biosynthetic process (GO:0006750) | 2.87436326 |
| 124 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.86780234 |
| 125 | macrophage activation involved in immune response (GO:0002281) | 2.86690176 |
| 126 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.86422914 |
| 127 | defense response to protozoan (GO:0042832) | 2.85057623 |
| 128 | arginine catabolic process (GO:0006527) | 2.84142354 |
| 129 | T cell homeostasis (GO:0043029) | 2.83977095 |
| 130 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.83831353 |
| 131 | drug transmembrane transport (GO:0006855) | 2.83737873 |
| 132 | antimicrobial humoral response (GO:0019730) | 2.83092779 |
| 133 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.82793298 |
| 134 | Peyers patch development (GO:0048541) | 2.82793298 |
| 135 | myeloid cell activation involved in immune response (GO:0002275) | 2.81961659 |
| 136 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.81367743 |
| 137 | mature B cell differentiation involved in immune response (GO:0002313) | 2.81109078 |
| 138 | diterpenoid biosynthetic process (GO:0016102) | 2.80400376 |
| 139 | neutrophil activation (GO:0042119) | 2.79622995 |
| 140 | digestion (GO:0007586) | 2.79506440 |
| 141 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.79446206 |
| 142 | positive regulation of antigen processing and presentation (GO:0002579) | 2.79223391 |
| 143 | lipoprotein transport (GO:0042953) | 2.79024202 |
| 144 | alkaloid metabolic process (GO:0009820) | 2.78553706 |
| 145 | leukocyte cell-cell adhesion (GO:0007159) | 2.77375439 |
| 146 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.77013028 |
| 147 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.77013028 |
| 148 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.75727459 |
| 149 | granulocyte activation (GO:0036230) | 2.75695756 |
| 150 | drug transport (GO:0015893) | 2.75389002 |
| 151 | regulation of systemic arterial blood pressure (GO:0003073) | 2.75201925 |
| 152 | B cell homeostasis (GO:0001782) | 2.74569942 |
| 153 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.74378942 |
| 154 | response to host immune response (GO:0052572) | 2.74378942 |
| 155 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.72765396 |
| 156 | positive regulation of macrophage differentiation (GO:0045651) | 2.71716979 |
| 157 | urate metabolic process (GO:0046415) | 2.69873679 |
| 158 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.69303233 |
| 159 | endocrine process (GO:0050886) | 2.69303233 |
| 160 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.69303233 |
| 161 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.69062919 |
| 162 | response to peptidoglycan (GO:0032494) | 2.68857882 |
| 163 | NADH metabolic process (GO:0006734) | 2.68588072 |
| 164 | digestive system process (GO:0022600) | 2.68013022 |
| 165 | natural killer cell activation (GO:0030101) | 2.66921974 |
| 166 | polarized epithelial cell differentiation (GO:0030859) | 2.66152062 |
| 167 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.66117725 |
| 168 | excretion (GO:0007588) | 2.65638982 |
| 169 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.65532574 |
| 170 | thyroid hormone metabolic process (GO:0042403) | 2.65134988 |
| 171 | cellular response to interferon-beta (GO:0035458) | 2.64277128 |
| 172 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.64156415 |
| 173 | primary alcohol metabolic process (GO:0034308) | 2.63479262 |
| 174 | multicellular organismal water homeostasis (GO:0050891) | 2.62993654 |
| 175 | negative thymic T cell selection (GO:0045060) | 2.62390566 |
| 176 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.62280994 |
| 177 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.61597698 |
| 178 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.61187714 |
| 179 | vitamin biosynthetic process (GO:0009110) | 2.60806458 |
| 180 | response to interferon-beta (GO:0035456) | 2.59640510 |
| 181 | response to fungus (GO:0009620) | 2.58197877 |
| 182 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.58149310 |
| 183 | response to host (GO:0075136) | 2.58149310 |
| 184 | response to host defenses (GO:0052200) | 2.58149310 |
| 185 | actin filament polymerization (GO:0030041) | 2.56909330 |
| 186 | dendritic cell migration (GO:0036336) | 2.56083189 |
| 187 | lymphocyte homeostasis (GO:0002260) | 2.54298712 |
| 188 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.53932513 |
| 189 | growth hormone receptor signaling pathway (GO:0060396) | 2.53365258 |
| 190 | dendritic cell chemotaxis (GO:0002407) | 2.53316095 |
| 191 | positive regulation of histone deacetylation (GO:0031065) | 2.53064766 |
| 192 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.51946191 |
| 193 | negative T cell selection (GO:0043383) | 2.51751104 |
| 194 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.51464217 |
| 195 | negative regulation of B cell proliferation (GO:0030889) | 2.51309035 |
| 196 | positive regulation of interferon-beta production (GO:0032728) | 2.51086706 |
| 197 | positive regulation of lamellipodium assembly (GO:0010592) | 2.50942623 |
| 198 | NIK/NF-kappaB signaling (GO:0038061) | 2.49080023 |
| 199 | response to muramyl dipeptide (GO:0032495) | 2.48828251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.92279979 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.10189280 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.82116469 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.50337399 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.46770998 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.44309738 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.40978195 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.39802806 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.27959346 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.09946584 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.09085070 |
| 12 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.05339731 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.03344682 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.89647105 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89125239 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.86415236 |
| 17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.75219963 |
| 18 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.73325552 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.70898092 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.69899722 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.68847489 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.65155689 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.63903768 |
| 24 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.59732260 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.58053668 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 2.56963305 |
| 27 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.52592998 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 2.52336762 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.50014888 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42958099 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 2.40421682 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.38045146 |
| 33 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.30868154 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.29595070 |
| 35 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 2.29315780 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.24910447 |
| 37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.23610531 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.21550397 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.21252208 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.19300722 |
| 41 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.17130030 |
| 42 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.17130030 |
| 43 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.17130030 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15773631 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.14595626 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 2.13786663 |
| 47 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.12726625 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.06018346 |
| 49 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.03672584 |
| 50 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 2.02537251 |
| 51 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00595321 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.99661281 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96086723 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.94153918 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.93220259 |
| 56 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.92184007 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.89308517 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.87703964 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.85118886 |
| 60 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.85063730 |
| 61 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.83543716 |
| 62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83281244 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.78087325 |
| 64 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.73409157 |
| 65 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.70900427 |
| 66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.63322227 |
| 67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.58315029 |
| 68 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.57775221 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.57543159 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55161889 |
| 71 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.54619155 |
| 72 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.51064784 |
| 73 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.50464974 |
| 74 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.50354946 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.50332291 |
| 76 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.50208612 |
| 77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.50063857 |
| 78 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48564206 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47181108 |
| 80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.46587513 |
| 81 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.45869822 |
| 82 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.45299220 |
| 83 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.45299220 |
| 84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.44814699 |
| 85 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.44800151 |
| 86 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44713645 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 1.44174286 |
| 88 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.43342138 |
| 89 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42633783 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41408673 |
| 91 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.40317666 |
| 92 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.39265832 |
| 93 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.38969392 |
| 94 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36992575 |
| 95 | AR_20517297_ChIP-Seq_VCAP_Human | 1.36546261 |
| 96 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35564844 |
| 97 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34553739 |
| 98 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30717695 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28006361 |
| 100 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.26798873 |
| 101 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.26441407 |
| 102 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26225261 |
| 103 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26182315 |
| 104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25389033 |
| 105 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24239720 |
| 106 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22871565 |
| 107 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.22663545 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22366364 |
| 109 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.21981861 |
| 110 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21504659 |
| 111 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.21339598 |
| 112 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21039041 |
| 113 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.19988560 |
| 114 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.19718080 |
| 115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18659529 |
| 116 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.17763788 |
| 117 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.17652657 |
| 118 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16046251 |
| 119 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.14506348 |
| 120 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.13235515 |
| 121 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12979534 |
| 122 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12934585 |
| 123 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11903094 |
| 124 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10906439 |
| 125 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10764283 |
| 126 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.10503624 |
| 127 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.09812728 |
| 128 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.08841966 |
| 129 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08442719 |
| 130 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.08372459 |
| 131 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.07341830 |
| 132 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06149783 |
| 133 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05078349 |
| 134 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03980947 |
| 135 | ERA_21632823_ChIP-Seq_H3396_Human | 1.03516534 |
| 136 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.02859692 |
| 137 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02607626 |
| 138 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02016265 |
| 139 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01975961 |
| 140 | P300_27268052_Chip-Seq_Bcells_Human | 1.01387686 |
| 141 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01089704 |
| 142 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00601194 |
| 143 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.00540772 |
| 144 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.99253488 |
| 145 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99080742 |
| 146 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98768816 |
| 147 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94988287 |
| 148 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94954589 |
| 149 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94849947 |
| 150 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.93638654 |
| 151 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93361957 |
| 152 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.92884396 |
| 153 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92731676 |
| 154 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.92674801 |
| 155 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.92661533 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92628290 |
| 157 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.92474228 |
| 158 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.92293935 |
| 159 | * CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.92087749 |
| 160 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91854471 |
| 161 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.91327081 |
| 162 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90296350 |
| 163 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89813630 |
| 164 | NCOR_22424771_ChIP-Seq_293T_Human | 0.89706322 |
| 165 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.87989832 |
| 166 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87712016 |
| 167 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86974754 |
| 168 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86658054 |
| 169 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86420120 |
| 170 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.86072162 |
| 171 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.85956287 |
| 172 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85882807 |
| 173 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85440219 |
| 174 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84897627 |
| 175 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.84456379 |
| 176 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84330497 |
| 177 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.84257209 |
| 178 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84172818 |
| 179 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83970425 |
| 180 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83437462 |
| 181 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81570811 |
| 182 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80278242 |
| 183 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.78105408 |
| 184 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77728640 |
| 185 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.77456459 |
| 186 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.77374583 |
| 187 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.77237146 |
| 188 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76894987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.89072338 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 3.78267259 |
| 3 | MP0003300_gastrointestinal_ulcer | 3.29501770 |
| 4 | MP0003303_peritoneal_inflammation | 3.28563942 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 3.23434827 |
| 6 | MP0005365_abnormal_bile_salt | 3.12565238 |
| 7 | MP0001873_stomach_inflammation | 2.98349787 |
| 8 | MP0003436_decreased_susceptibility_to | 2.90252913 |
| 9 | MP0003866_abnormal_defecation | 2.86370219 |
| 10 | MP0005671_abnormal_response_to | 2.84421361 |
| 11 | MP0009785_altered_susceptibility_to | 2.82860431 |
| 12 | MP0000566_synostosis | 2.79425645 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.73352040 |
| 14 | MP0001800_abnormal_humoral_immune | 2.70809993 |
| 15 | MP0003941_abnormal_skin_development | 2.65044914 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.59879670 |
| 17 | MP0005025_abnormal_response_to | 2.59260047 |
| 18 | MP0000685_abnormal_immune_system | 2.58202672 |
| 19 | MP0001790_abnormal_immune_system | 2.56254218 |
| 20 | MP0005387_immune_system_phenotype | 2.56254218 |
| 21 | MP0010155_abnormal_intestine_physiology | 2.56044620 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.55988677 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.55821722 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.53996813 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 2.42120226 |
| 26 | MP0001819_abnormal_immune_cell | 2.39254326 |
| 27 | MP0002723_abnormal_immune_serum | 2.38252175 |
| 28 | MP0002420_abnormal_adaptive_immunity | 2.37733156 |
| 29 | MP0002419_abnormal_innate_immunity | 2.33859493 |
| 30 | MP0005464_abnormal_platelet_physiology | 2.28014796 |
| 31 | MP0003718_maternal_effect | 2.24021950 |
| 32 | MP0004043_abnormal_pH_regulation | 2.22380420 |
| 33 | MP0003183_abnormal_peptide_metabolism | 2.21078260 |
| 34 | MP0002396_abnormal_hematopoietic_system | 2.18301852 |
| 35 | MP0000490_abnormal_crypts_of | 2.17212907 |
| 36 | MP0004947_skin_inflammation | 2.14596530 |
| 37 | MP0006082_CNS_inflammation | 2.14193697 |
| 38 | MP0002796_impaired_skin_barrier | 2.13408439 |
| 39 | MP0002166_altered_tumor_susceptibility | 2.09710736 |
| 40 | MP0005310_abnormal_salivary_gland | 2.09532641 |
| 41 | MP0002398_abnormal_bone_marrow | 2.08051707 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.99042342 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.93952418 |
| 44 | MP0000716_abnormal_immune_system | 1.91516480 |
| 45 | MP0002098_abnormal_vibrissa_morphology | 1.90870537 |
| 46 | MP0004782_abnormal_surfactant_physiolog | 1.88359751 |
| 47 | MP0002006_tumorigenesis | 1.83442103 |
| 48 | MP0002405_respiratory_system_inflammati | 1.82467450 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.78413816 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.77446651 |
| 51 | MP0001881_abnormal_mammary_gland | 1.77279645 |
| 52 | MP0003890_abnormal_embryonic-extraembry | 1.76760697 |
| 53 | MP0009379_abnormal_foot_pigmentation | 1.75819737 |
| 54 | MP0002254_reproductive_system_inflammat | 1.75017291 |
| 55 | MP0010329_abnormal_lipoprotein_level | 1.72070607 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.71171894 |
| 57 | MP0002876_abnormal_thyroid_physiology | 1.70639482 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.68182724 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 1.66953129 |
| 60 | MP0001663_abnormal_digestive_system | 1.66789755 |
| 61 | MP0005332_abnormal_amino_acid | 1.65889931 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.64594357 |
| 63 | MP0010678_abnormal_skin_adnexa | 1.64118566 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.62975242 |
| 65 | MP0002722_abnormal_immune_system | 1.62062893 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.61904147 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.61904147 |
| 68 | MP0003195_calcinosis | 1.60628223 |
| 69 | MP0002429_abnormal_blood_cell | 1.60343166 |
| 70 | MP0008872_abnormal_physiological_respon | 1.59751208 |
| 71 | MP0009278_abnormal_bone_marrow | 1.58332829 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 1.56941218 |
| 73 | MP0004264_abnormal_extraembryonic_tissu | 1.55681562 |
| 74 | MP0001764_abnormal_homeostasis | 1.55564850 |
| 75 | MP0004510_myositis | 1.46476512 |
| 76 | MP0000537_abnormal_urethra_morphology | 1.45815766 |
| 77 | MP0001853_heart_inflammation | 1.45347940 |
| 78 | MP0005377_hearing/vestibular/ear_phenot | 1.44310360 |
| 79 | MP0003878_abnormal_ear_physiology | 1.44310360 |
| 80 | MP0000383_abnormal_hair_follicle | 1.43862500 |
| 81 | MP0003724_increased_susceptibility_to | 1.43198169 |
| 82 | MP0001533_abnormal_skeleton_physiology | 1.39002262 |
| 83 | MP0009643_abnormal_urine_homeostasis | 1.38649126 |
| 84 | MP0000678_abnormal_parathyroid_gland | 1.37078292 |
| 85 | MP0004957_abnormal_blastocyst_morpholog | 1.35941401 |
| 86 | MP0010307_abnormal_tumor_latency | 1.33764760 |
| 87 | MP0001485_abnormal_pinna_reflex | 1.30311595 |
| 88 | MP0005058_abnormal_lysosome_morphology | 1.29250158 |
| 89 | MP0003315_abnormal_perineum_morphology | 1.28514922 |
| 90 | MP0003448_altered_tumor_morphology | 1.27725922 |
| 91 | MP0001666_abnormal_nutrient_absorption | 1.26638643 |
| 92 | MP0008469_abnormal_protein_level | 1.26613390 |
| 93 | MP0008877_abnormal_DNA_methylation | 1.25775201 |
| 94 | MP0000858_altered_metastatic_potential | 1.23045602 |
| 95 | MP0000427_abnormal_hair_cycle | 1.19256318 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 1.18449035 |
| 97 | MP0000579_abnormal_nail_morphology | 1.17130911 |
| 98 | MP0003119_abnormal_digestive_system | 1.16526451 |
| 99 | MP0005501_abnormal_skin_physiology | 1.16260424 |
| 100 | MP0000703_abnormal_thymus_morphology | 1.16048753 |
| 101 | MP0000538_abnormal_urinary_bladder | 1.15117363 |
| 102 | MP0001188_hyperpigmentation | 1.09029678 |
| 103 | MP0000477_abnormal_intestine_morphology | 1.06968283 |
| 104 | MP0005166_decreased_susceptibility_to | 1.06844498 |
| 105 | MP0005083_abnormal_biliary_tract | 1.02990982 |
| 106 | MP0003567_abnormal_fetal_cardiomyocyte | 1.02938857 |
| 107 | MP0003283_abnormal_digestive_organ | 1.00158160 |
| 108 | MP0005076_abnormal_cell_differentiation | 0.98793036 |
| 109 | MP0009764_decreased_sensitivity_to | 0.97837466 |
| 110 | MP0000569_abnormal_digit_pigmentation | 0.97464971 |
| 111 | MP0000467_abnormal_esophagus_morphology | 0.97406521 |
| 112 | MP0003172_abnormal_lysosome_physiology | 0.95053006 |
| 113 | MP0003045_fibrosis | 0.94471817 |
| 114 | MP0009840_abnormal_foam_cell | 0.93103409 |
| 115 | MP0002277_abnormal_respiratory_mucosa | 0.93022681 |
| 116 | MP0000377_abnormal_hair_follicle | 0.85212715 |
| 117 | MP0003638_abnormal_response/metabolism_ | 0.84963104 |
| 118 | MP0005395_other_phenotype | 0.84832138 |
| 119 | MP0003693_abnormal_embryo_hatching | 0.84668681 |
| 120 | MP0002019_abnormal_tumor_incidence | 0.84586089 |
| 121 | MP0003075_altered_response_to | 0.84186614 |
| 122 | MP0004147_increased_porphyrin_level | 0.82632437 |
| 123 | MP0004133_heterotaxia | 0.81035037 |
| 124 | MP0002118_abnormal_lipid_homeostasis | 0.80875673 |
| 125 | MP0000470_abnormal_stomach_morphology | 0.80821520 |
| 126 | MP0003191_abnormal_cellular_cholesterol | 0.79360001 |
| 127 | MP0005319_abnormal_enzyme/_coenzyme | 0.78128729 |
| 128 | MP0001851_eye_inflammation | 0.78102901 |
| 129 | MP0006054_spinal_hemorrhage | 0.77346858 |
| 130 | MP0002138_abnormal_hepatobiliary_system | 0.77130982 |
| 131 | MP0002998_abnormal_bone_remodeling | 0.75755525 |
| 132 | MP0001919_abnormal_reproductive_system | 0.74985627 |
| 133 | MP0000015_abnormal_ear_pigmentation | 0.74894582 |
| 134 | MP0002009_preneoplasia | 0.74807904 |
| 135 | MP0005360_urolithiasis | 0.74489772 |
| 136 | MP0002111_abnormal_tail_morphology | 0.71707929 |
| 137 | MP0001756_abnormal_urination | 0.71634416 |
| 138 | MP0002136_abnormal_kidney_physiology | 0.70475732 |
| 139 | MP0003252_abnormal_bile_duct | 0.69076405 |
| 140 | MP0008873_increased_physiological_sensi | 0.68571244 |
| 141 | MP0000627_abnormal_mammary_gland | 0.68555337 |
| 142 | MP0001501_abnormal_sleep_pattern | 0.68425100 |
| 143 | MP0000343_altered_response_to | 0.67426130 |
| 144 | MP0001664_abnormal_digestion | 0.66660917 |
| 145 | MP0001765_abnormal_ion_homeostasis | 0.66407348 |
| 146 | MP0000516_abnormal_urinary_system | 0.64883300 |
| 147 | MP0005367_renal/urinary_system_phenotyp | 0.64883300 |
| 148 | MP0000604_amyloidosis | 0.64704303 |
| 149 | MP0002933_joint_inflammation | 0.63918552 |
| 150 | MP0003868_abnormal_feces_composition | 0.63121613 |
| 151 | MP0008961_abnormal_basal_metabolism | 0.62897885 |
| 152 | MP0003566_abnormal_cell_adhesion | 0.62011677 |
| 153 | MP0002132_abnormal_respiratory_system | 0.61718650 |
| 154 | MP0003656_abnormal_erythrocyte_physiolo | 0.59661649 |
| 155 | MP0003453_abnormal_keratinocyte_physiol | 0.59126512 |
| 156 | MP0005410_abnormal_fertilization | 0.59068748 |
| 157 | MP0003953_abnormal_hormone_level | 0.57613414 |
| 158 | MP0003011_delayed_dark_adaptation | 0.57466190 |
| 159 | MP0001216_abnormal_epidermal_layer | 0.56029216 |
| 160 | MP0000249_abnormal_blood_vessel | 0.55222748 |
| 161 | MP0005670_abnormal_white_adipose | 0.55153985 |
| 162 | MP0009931_abnormal_skin_appearance | 0.54959296 |
| 163 | MP0005389_reproductive_system_phenotype | 0.54717602 |
| 164 | MP0000647_abnormal_sebaceous_gland | 0.54641178 |
| 165 | MP0002909_abnormal_adrenal_gland | 0.54629116 |
| 166 | MP0005075_abnormal_melanosome_morpholog | 0.54628708 |
| 167 | MP0005448_abnormal_energy_balance | 0.53549098 |
| 168 | MP0009763_increased_sensitivity_to | 0.51057142 |
| 169 | MP0009765_abnormal_xenobiotic_induced | 0.51023954 |
| 170 | MP0009115_abnormal_fat_cell | 0.50188525 |
| 171 | MP0000609_abnormal_liver_physiology | 0.49086934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.83928956 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.74964000 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.63281797 |
| 4 | Chronic otitis media (HP:0000389) | 4.46548021 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.37824755 |
| 6 | Myositis (HP:0100614) | 4.36267796 |
| 7 | Hyperactive renin-angiotensin system (HP:0000841) | 4.30091201 |
| 8 | Recurrent viral infections (HP:0004429) | 4.26913832 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.18508944 |
| 10 | Decreased circulating renin level (HP:0003351) | 4.06127550 |
| 11 | Chronic bronchitis (HP:0004469) | 4.04274699 |
| 12 | Nasal polyposis (HP:0100582) | 3.99463617 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.94661842 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 3.91485757 |
| 15 | Cellulitis (HP:0100658) | 3.91198831 |
| 16 | IgM deficiency (HP:0002850) | 3.90484115 |
| 17 | Hyperglycinuria (HP:0003108) | 3.79900932 |
| 18 | Recurrent bronchitis (HP:0002837) | 3.70372461 |
| 19 | Inflammation of the large intestine (HP:0002037) | 3.60842546 |
| 20 | Thrombocytosis (HP:0001894) | 3.54848174 |
| 21 | Gastrointestinal inflammation (HP:0004386) | 3.54207302 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.52776497 |
| 23 | Petechiae (HP:0000967) | 3.48834571 |
| 24 | Colitis (HP:0002583) | 3.44811684 |
| 25 | Abnormality of renin-angiotensin system (HP:0000847) | 3.43167117 |
| 26 | Abnormality of the nasal mucosa (HP:0000433) | 3.42724247 |
| 27 | Abnormality of macrophages (HP:0004311) | 3.40845694 |
| 28 | Orchitis (HP:0100796) | 3.40332746 |
| 29 | Interstitial pulmonary disease (HP:0006530) | 3.36737485 |
| 30 | Malnutrition (HP:0004395) | 3.36028832 |
| 31 | Agammaglobulinemia (HP:0004432) | 3.35035781 |
| 32 | Meningitis (HP:0001287) | 3.33677966 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 3.27142377 |
| 34 | Vasculitis (HP:0002633) | 3.23292251 |
| 35 | Hypobetalipoproteinemia (HP:0003563) | 3.22744720 |
| 36 | Pustule (HP:0200039) | 3.22271191 |
| 37 | Retrobulbar optic neuritis (HP:0100654) | 3.22033541 |
| 38 | Optic neuritis (HP:0100653) | 3.22033541 |
| 39 | Right ventricular cardiomyopathy (HP:0011663) | 3.20391696 |
| 40 | Abnormality of glycine metabolism (HP:0010895) | 3.19345056 |
| 41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.19345056 |
| 42 | Increased IgE level (HP:0003212) | 3.13764272 |
| 43 | Hydroxyprolinuria (HP:0003080) | 3.13360990 |
| 44 | Abnormality of proline metabolism (HP:0010907) | 3.13360990 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 3.13069264 |
| 46 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.07496160 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 3.04694693 |
| 48 | Abnormality of vitamin B metabolism (HP:0004340) | 2.99719181 |
| 49 | Recurrent skin infections (HP:0001581) | 2.98522360 |
| 50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.96586346 |
| 51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.96586346 |
| 52 | Autoimmune hemolytic anemia (HP:0001890) | 2.89895957 |
| 53 | Chronic diarrhea (HP:0002028) | 2.88777458 |
| 54 | Abnormality of T cells (HP:0002843) | 2.88092723 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84325445 |
| 56 | Obstructive lung disease (HP:0006536) | 2.84325445 |
| 57 | Osteomyelitis (HP:0002754) | 2.79962694 |
| 58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78688035 |
| 59 | Intrahepatic cholestasis (HP:0001406) | 2.78522907 |
| 60 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.77812247 |
| 61 | Pili torti (HP:0003777) | 2.74394925 |
| 62 | Thyroiditis (HP:0100646) | 2.70207979 |
| 63 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.69000661 |
| 64 | Abnormal hair laboratory examination (HP:0003328) | 2.67791985 |
| 65 | Abnormality of vitamin metabolism (HP:0100508) | 2.65692605 |
| 66 | Arterial thrombosis (HP:0004420) | 2.65206851 |
| 67 | Panhypogammaglobulinemia (HP:0003139) | 2.62232986 |
| 68 | Alkalosis (HP:0001948) | 2.61634276 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.61241982 |
| 70 | Abnormal platelet function (HP:0011869) | 2.61241982 |
| 71 | Gingivitis (HP:0000230) | 2.56602598 |
| 72 | T lymphocytopenia (HP:0005403) | 2.55497266 |
| 73 | Lymphopenia (HP:0001888) | 2.55097172 |
| 74 | Prolonged bleeding time (HP:0003010) | 2.52651498 |
| 75 | Fat malabsorption (HP:0002630) | 2.52424853 |
| 76 | Fatigue (HP:0012378) | 2.51828434 |
| 77 | Ileus (HP:0002595) | 2.51407610 |
| 78 | Acanthocytosis (HP:0001927) | 2.51268074 |
| 79 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.49376794 |
| 80 | Papilloma (HP:0012740) | 2.49244454 |
| 81 | Verrucae (HP:0200043) | 2.49244454 |
| 82 | Abnormality of T cell number (HP:0011839) | 2.48607112 |
| 83 | Encephalitis (HP:0002383) | 2.48257901 |
| 84 | Periodontitis (HP:0000704) | 2.44386244 |
| 85 | Abnormal platelet volume (HP:0011876) | 2.43000652 |
| 86 | Pigmentary retinal degeneration (HP:0001146) | 2.42579425 |
| 87 | Chronic sinusitis (HP:0011109) | 2.41902925 |
| 88 | Abnormality of B cell number (HP:0010975) | 2.40967207 |
| 89 | B lymphocytopenia (HP:0010976) | 2.40967207 |
| 90 | Abnormality of chloride homeostasis (HP:0011422) | 2.40675730 |
| 91 | Spontaneous hematomas (HP:0007420) | 2.40410723 |
| 92 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.39005263 |
| 93 | IgA deficiency (HP:0002720) | 2.37458941 |
| 94 | Metabolic alkalosis (HP:0200114) | 2.37169257 |
| 95 | Abnormality of the fingertips (HP:0001211) | 2.34446422 |
| 96 | Chest pain (HP:0100749) | 2.33472966 |
| 97 | Sepsis (HP:0100806) | 2.33363041 |
| 98 | Rhinitis (HP:0012384) | 2.33216313 |
| 99 | Hyperaldosteronism (HP:0000859) | 2.32590934 |
| 100 | Gastrointestinal stroma tumor (HP:0100723) | 2.32038482 |
| 101 | Abnormal biliary tract morphology (HP:0012440) | 2.30728358 |
| 102 | Disinhibition (HP:0000734) | 2.30054142 |
| 103 | Hypoplasia of the uterus (HP:0000013) | 2.29388547 |
| 104 | Widely patent fontanelles and sutures (HP:0004492) | 2.27176343 |
| 105 | Amelogenesis imperfecta (HP:0000705) | 2.26893782 |
| 106 | Woolly hair (HP:0002224) | 2.26541146 |
| 107 | Confusion (HP:0001289) | 2.26487270 |
| 108 | Bronchitis (HP:0012387) | 2.24989103 |
| 109 | Bronchiectasis (HP:0002110) | 2.24459009 |
| 110 | Increased cerebral lipofuscin (HP:0011813) | 2.24233994 |
| 111 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.18672203 |
| 112 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.18672203 |
| 113 | Breast hypoplasia (HP:0003187) | 2.18489137 |
| 114 | Hypergammaglobulinemia (HP:0010702) | 2.17204825 |
| 115 | Keratoconjunctivitis sicca (HP:0001097) | 2.16949776 |
| 116 | Pulmonary infiltrates (HP:0002113) | 2.15146233 |
| 117 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.14690435 |
| 118 | Plantar hyperkeratosis (HP:0007556) | 2.14484658 |
| 119 | Abnormality of urine glucose concentration (HP:0011016) | 2.13756374 |
| 120 | Glycosuria (HP:0003076) | 2.13756374 |
| 121 | Villous atrophy (HP:0011473) | 2.12444763 |
| 122 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.12444763 |
| 123 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.11845909 |
| 124 | Abnormality of serum amino acid levels (HP:0003112) | 2.11619799 |
| 125 | Hemoptysis (HP:0002105) | 2.11529038 |
| 126 | Birth length less than 3rd percentile (HP:0003561) | 2.11512678 |
| 127 | Biliary tract neoplasm (HP:0100574) | 2.11225707 |
| 128 | Recurrent sinusitis (HP:0011108) | 2.10403294 |
| 129 | Skin ulcer (HP:0200042) | 2.10306419 |
| 130 | Stomach cancer (HP:0012126) | 2.10242236 |
| 131 | Stomatitis (HP:0010280) | 2.09948403 |
| 132 | Cheilitis (HP:0100825) | 2.09634830 |
| 133 | Abnormality of the prostate (HP:0008775) | 2.09601297 |
| 134 | Leukocytosis (HP:0001974) | 2.09320957 |
| 135 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.09083229 |
| 136 | Absent/shortened dynein arms (HP:0200106) | 2.09083229 |
| 137 | Hematochezia (HP:0002573) | 2.08283616 |
| 138 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.07862121 |
| 139 | Prostate neoplasm (HP:0100787) | 2.07381169 |
| 140 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.02163176 |
| 141 | Hyperglycinemia (HP:0002154) | 2.02109416 |
| 142 | Fragile nails (HP:0001808) | 2.00967097 |
| 143 | Gingival bleeding (HP:0000225) | 2.00721153 |
| 144 | Increased mean platelet volume (HP:0011877) | 1.96722152 |
| 145 | Papilledema (HP:0001085) | 1.95990944 |
| 146 | Eosinophilia (HP:0001880) | 1.95476242 |
| 147 | Hyperammonemia (HP:0001987) | 1.94914267 |
| 148 | Increased density of long bones (HP:0006392) | 1.94909936 |
| 149 | Urticaria (HP:0001025) | 1.94272256 |
| 150 | True hermaphroditism (HP:0010459) | 1.93963882 |
| 151 | Severe combined immunodeficiency (HP:0004430) | 1.91850766 |
| 152 | Megaloblastic anemia (HP:0001889) | 1.91167082 |
| 153 | Gonadal dysgenesis (HP:0000133) | 1.91164265 |
| 154 | Keratoconjunctivitis (HP:0001096) | 1.90834579 |
| 155 | Palmoplantar hyperkeratosis (HP:0000972) | 1.90525530 |
| 156 | Abnormality of eosinophils (HP:0001879) | 1.90346804 |
| 157 | Epistaxis (HP:0000421) | 1.90308369 |
| 158 | Viral hepatitis (HP:0006562) | 1.90298477 |
| 159 | Combined immunodeficiency (HP:0005387) | 1.89111757 |
| 160 | Curly hair (HP:0002212) | 1.88984994 |
| 161 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88591093 |
| 162 | Alopecia of scalp (HP:0002293) | 1.87169471 |
| 163 | Hypoplastic labia majora (HP:0000059) | 1.86884370 |
| 164 | Osteomalacia (HP:0002749) | 1.86460494 |
| 165 | Proximal tubulopathy (HP:0000114) | 1.81873662 |
| 166 | Flat acetabular roof (HP:0003180) | 1.81817642 |
| 167 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.81469926 |
| 168 | Epidermoid cyst (HP:0200040) | 1.79693935 |
| 169 | Palmar hyperkeratosis (HP:0010765) | 1.79536762 |
| 170 | Genu varum (HP:0002970) | 1.79211884 |
| 171 | Abnormal ciliary motility (HP:0012262) | 1.78185909 |
| 172 | Abnormality of homocysteine metabolism (HP:0010919) | 1.76599340 |
| 173 | Homocystinuria (HP:0002156) | 1.76599340 |
| 174 | Pendular nystagmus (HP:0012043) | 1.75921457 |
| 175 | Conjugated hyperbilirubinemia (HP:0002908) | 1.74936286 |
| 176 | Pancreatic cysts (HP:0001737) | 1.74928595 |
| 177 | Focal segmental glomerulosclerosis (HP:0000097) | 1.74040435 |
| 178 | Abolished electroretinogram (ERG) (HP:0000550) | 1.73408788 |
| 179 | Metabolic acidosis (HP:0001942) | 1.73270811 |
| 180 | Microretrognathia (HP:0000308) | 1.71738959 |
| 181 | Labial hypoplasia (HP:0000066) | 1.69643292 |
| 182 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.68472203 |
| 183 | Chronic hepatic failure (HP:0100626) | 1.68053391 |
| 184 | Abnormality of the nasal septum (HP:0000419) | 1.67823845 |
| 185 | Hypoplastic female external genitalia (HP:0012815) | 1.66262108 |
| 186 | Dehydration (HP:0001944) | 1.64936215 |
| 187 | Renal salt wasting (HP:0000127) | 1.64125745 |
| 188 | Tubular atrophy (HP:0000092) | 1.64051043 |
| 189 | Lip pit (HP:0100267) | 1.63952675 |
| 190 | Glomerulosclerosis (HP:0000096) | 1.63818396 |
| 191 | Abnormal urine phosphate concentration (HP:0012599) | 1.63218908 |
| 192 | Male pseudohermaphroditism (HP:0000037) | 1.63003679 |
| 193 | Lethargy (HP:0001254) | 1.61883271 |
| 194 | Abnormality of the renal cortex (HP:0011035) | 1.60578537 |
| 195 | Bilateral microphthalmos (HP:0007633) | 1.59331993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 6.18737824 |
| 2 | EPHA2 | 5.08118857 |
| 3 | MAP4K1 | 4.12292327 |
| 4 | EEF2K | 3.95451149 |
| 5 | RIPK4 | 2.82037471 |
| 6 | NME1 | 2.77150869 |
| 7 | STK39 | 2.70532039 |
| 8 | MST4 | 2.62711911 |
| 9 | TBK1 | 2.53584004 |
| 10 | ERN1 | 2.48386453 |
| 11 | PDK2 | 2.48304923 |
| 12 | OXSR1 | 2.45721443 |
| 13 | TYK2 | 2.36305271 |
| 14 | TAOK3 | 2.28865016 |
| 15 | WNK4 | 2.24855253 |
| 16 | BLK | 2.20583712 |
| 17 | JAK3 | 2.18807599 |
| 18 | GRK6 | 2.14573916 |
| 19 | KIT | 2.10204146 |
| 20 | PKN2 | 2.05393005 |
| 21 | MET | 2.03952579 |
| 22 | FRK | 2.03146669 |
| 23 | STK10 | 1.97489979 |
| 24 | TLK1 | 1.96791345 |
| 25 | MAP3K10 | 1.89051708 |
| 26 | BTK | 1.88402032 |
| 27 | ZAP70 | 1.86332750 |
| 28 | TXK | 1.86085010 |
| 29 | BMPR1B | 1.84627734 |
| 30 | MATK | 1.82147963 |
| 31 | IKBKE | 1.81874940 |
| 32 | IRAK4 | 1.76939878 |
| 33 | TTK | 1.73851878 |
| 34 | ZAK | 1.72662322 |
| 35 | STK24 | 1.72639264 |
| 36 | SYK | 1.67980352 |
| 37 | MAP3K14 | 1.67759572 |
| 38 | TRIB3 | 1.65736873 |
| 39 | JAK1 | 1.65494959 |
| 40 | LRRK2 | 1.64625208 |
| 41 | EPHB1 | 1.54025473 |
| 42 | BRSK2 | 1.52067262 |
| 43 | CSF1R | 1.51825996 |
| 44 | GRK1 | 1.51774935 |
| 45 | STK38L | 1.48880591 |
| 46 | TNIK | 1.43440215 |
| 47 | PTK6 | 1.38245386 |
| 48 | NME2 | 1.37752869 |
| 49 | SIK2 | 1.35484288 |
| 50 | NUAK1 | 1.34387988 |
| 51 | PIM2 | 1.29977454 |
| 52 | SCYL2 | 1.29960775 |
| 53 | TESK1 | 1.27754819 |
| 54 | FES | 1.25799354 |
| 55 | IRAK3 | 1.25624140 |
| 56 | ADRBK2 | 1.25444544 |
| 57 | STK3 | 1.24180032 |
| 58 | CASK | 1.23431476 |
| 59 | PRKCI | 1.21754000 |
| 60 | LCK | 1.21293831 |
| 61 | LATS1 | 1.18735769 |
| 62 | PIM1 | 1.18697988 |
| 63 | IKBKB | 1.16140599 |
| 64 | FGFR3 | 1.13342713 |
| 65 | TEC | 1.11818573 |
| 66 | TSSK6 | 1.10413411 |
| 67 | MST1R | 1.09044117 |
| 68 | CSK | 1.08615524 |
| 69 | HCK | 1.08257086 |
| 70 | LMTK2 | 1.06219031 |
| 71 | RIPK1 | 1.03199101 |
| 72 | ITK | 1.02861711 |
| 73 | MAP3K13 | 1.02351695 |
| 74 | MKNK2 | 1.02176882 |
| 75 | FER | 1.00525112 |
| 76 | TGFBR1 | 1.00521818 |
| 77 | MAP3K2 | 0.99400285 |
| 78 | PBK | 0.95876755 |
| 79 | JAK2 | 0.95558668 |
| 80 | MAPK15 | 0.94212704 |
| 81 | SIK1 | 0.91976244 |
| 82 | FLT3 | 0.91841253 |
| 83 | DAPK2 | 0.90085379 |
| 84 | PRKG2 | 0.90065441 |
| 85 | CAMK1D | 0.90056193 |
| 86 | TAOK1 | 0.88460384 |
| 87 | PDK1 | 0.86407400 |
| 88 | MAP2K3 | 0.85612735 |
| 89 | LYN | 0.84969483 |
| 90 | MAPKAPK3 | 0.84900792 |
| 91 | RPS6KB2 | 0.80549179 |
| 92 | TNK2 | 0.80498804 |
| 93 | BMX | 0.78905527 |
| 94 | ERBB2 | 0.78797170 |
| 95 | MAP3K12 | 0.75462621 |
| 96 | FGFR4 | 0.73808857 |
| 97 | FGFR2 | 0.72964769 |
| 98 | RET | 0.72752199 |
| 99 | CLK1 | 0.72543611 |
| 100 | TESK2 | 0.71582666 |
| 101 | MAP3K8 | 0.69557504 |
| 102 | TRPM7 | 0.69369872 |
| 103 | KSR2 | 0.69316187 |
| 104 | MAP2K2 | 0.67101766 |
| 105 | PASK | 0.67080405 |
| 106 | CHUK | 0.64040420 |
| 107 | IRAK1 | 0.63668272 |
| 108 | PRKAA2 | 0.62892022 |
| 109 | ALK | 0.60978441 |
| 110 | CAMK1G | 0.60071327 |
| 111 | CDK6 | 0.60039321 |
| 112 | MAP4K2 | 0.55567405 |
| 113 | MARK3 | 0.55173054 |
| 114 | TRIM28 | 0.52786703 |
| 115 | PLK4 | 0.51385819 |
| 116 | STK4 | 0.49578750 |
| 117 | WNK3 | 0.48688171 |
| 118 | RPS6KA2 | 0.48128258 |
| 119 | MELK | 0.48122687 |
| 120 | EPHA3 | 0.48041901 |
| 121 | INSRR | 0.47687811 |
| 122 | SRPK1 | 0.47183704 |
| 123 | PDPK1 | 0.46864387 |
| 124 | AKT3 | 0.46673796 |
| 125 | NEK9 | 0.45754460 |
| 126 | PIK3CA | 0.45681613 |
| 127 | BCR | 0.44764234 |
| 128 | NEK2 | 0.43019341 |
| 129 | MAP3K1 | 0.42988675 |
| 130 | CDK19 | 0.42753446 |
| 131 | NEK6 | 0.42628861 |
| 132 | PRKCQ | 0.42535014 |
| 133 | MAP2K6 | 0.41149699 |
| 134 | SIK3 | 0.41120754 |
| 135 | MAPK11 | 0.41112538 |
| 136 | PLK1 | 0.40317835 |
| 137 | NLK | 0.39884179 |
| 138 | FGFR1 | 0.39316972 |
| 139 | PRKCZ | 0.39071317 |
| 140 | MAP3K7 | 0.38689466 |
| 141 | EIF2AK3 | 0.38570393 |
| 142 | MAPKAPK2 | 0.38271910 |
| 143 | CDK4 | 0.37953839 |
| 144 | TGFBR2 | 0.37912732 |
| 145 | PAK4 | 0.37603336 |
| 146 | RPS6KA4 | 0.37310074 |
| 147 | MAP3K11 | 0.36128726 |
| 148 | PLK3 | 0.35189930 |
| 149 | MAPK4 | 0.34435643 |
| 150 | CSNK1A1 | 0.33429390 |
| 151 | FGR | 0.33422379 |
| 152 | PRKCE | 0.29275293 |
| 153 | PRKCA | 0.28811720 |
| 154 | YES1 | 0.26844280 |
| 155 | IGF1R | 0.26718267 |
| 156 | EPHB2 | 0.26065774 |
| 157 | STK11 | 0.25859072 |
| 158 | MKNK1 | 0.25837382 |
| 159 | PINK1 | 0.23802930 |
| 160 | BUB1 | 0.23271812 |
| 161 | RPS6KA6 | 0.20830887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.83521863 |
| 2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.57929598 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.74744973 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.57818869 |
| 5 | Histidine metabolism_Homo sapiens_hsa00340 | 2.57594488 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41208508 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.40382672 |
| 8 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.40328757 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.36802768 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.28261566 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.26894823 |
| 12 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.23094288 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.20723402 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.16498371 |
| 15 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.16347250 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.11538637 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.10238411 |
| 18 | Retinol metabolism_Homo sapiens_hsa00830 | 2.10180902 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.09262936 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.94317457 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93029521 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.90508699 |
| 23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.87595476 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.86718978 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.85740499 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.83961710 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.83923198 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80673727 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.78825619 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77985228 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.77961747 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.76708084 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.74866212 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67521980 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.65983968 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.60232566 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.60171770 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59820782 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59503868 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.54037799 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.53365058 |
| 42 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52774769 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.52349968 |
| 44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.51402456 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.50248103 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50049943 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.49567057 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 1.49378620 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48462905 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.48164994 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 1.47757165 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 1.47742766 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.47444022 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 1.45959955 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.44961732 |
| 56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.43594947 |
| 57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43355333 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.42473202 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.40171293 |
| 60 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.39876898 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 1.39261548 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.34491922 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.33839680 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33383179 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 1.32527539 |
| 66 | Asthma_Homo sapiens_hsa05310 | 1.30706095 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28196075 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.27880974 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27722130 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 1.27431762 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 1.27231763 |
| 72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.26447243 |
| 73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.25487851 |
| 74 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.22026977 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21007419 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.20289782 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 1.16065224 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 1.15467285 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.15032511 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14846846 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 1.12826735 |
| 82 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.12525535 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08511258 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 1.08193931 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08100587 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.07701211 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.07410125 |
| 88 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.05641603 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04800791 |
| 90 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.04343118 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00977065 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.00241348 |
| 93 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00137882 |
| 94 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99849361 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99283465 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98964557 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97460980 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.96735624 |
| 99 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95711622 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94183798 |
| 101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94068227 |
| 102 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92977700 |
| 103 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.92206644 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91083826 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.90438500 |
| 106 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88955158 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.85751642 |
| 108 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.84787491 |
| 109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.84620613 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84370088 |
| 111 | Malaria_Homo sapiens_hsa05144 | 0.79663289 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72676792 |
| 113 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72636998 |
| 114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72421473 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71406633 |
| 116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71236927 |
| 117 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70843180 |
| 118 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.68819754 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68740582 |
| 120 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67224655 |
| 121 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67010487 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66676455 |
| 123 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66011212 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65981220 |
| 125 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64906602 |
| 126 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.64254398 |
| 127 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63610786 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.63223613 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63119617 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61567513 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56750032 |
| 132 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56496601 |
| 133 | Amoebiasis_Homo sapiens_hsa05146 | 0.56200504 |
| 134 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56133311 |
| 135 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56055754 |
| 136 | Homologous recombination_Homo sapiens_hsa03440 | 0.55918844 |
| 137 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55829553 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55572084 |
| 139 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55102757 |
| 140 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54649921 |
| 141 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54455275 |
| 142 | Endocytosis_Homo sapiens_hsa04144 | 0.52305021 |
| 143 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.51965780 |
| 144 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51530058 |
| 145 | Tight junction_Homo sapiens_hsa04530 | 0.51021654 |
| 146 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50791237 |
| 147 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49775792 |
| 148 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47963171 |
| 149 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47244405 |
| 150 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46606424 |
| 151 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46532355 |
| 152 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46292529 |
| 153 | Phagosome_Homo sapiens_hsa04145 | 0.46130572 |
| 154 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45652549 |
| 155 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.44635538 |
| 156 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44534163 |
| 157 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44307491 |
| 158 | Insulin resistance_Homo sapiens_hsa04931 | 0.43754703 |
| 159 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43262611 |
| 160 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.42713606 |
| 161 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40914358 |
| 162 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40414708 |
| 163 | Glioma_Homo sapiens_hsa05214 | 0.39788758 |
| 164 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39256563 |
| 165 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39208246 |
| 166 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38310767 |
| 167 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38012814 |
| 168 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36353703 |
| 169 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.36304397 |
| 170 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.30733239 |
| 171 | RNA polymerase_Homo sapiens_hsa03020 | 0.26670374 |
| 172 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.26221458 |
| 173 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22513046 |
| 174 | Phototransduction_Homo sapiens_hsa04744 | 0.20504088 |
| 175 | Mismatch repair_Homo sapiens_hsa03430 | 0.20121626 |
| 176 | Purine metabolism_Homo sapiens_hsa00230 | 0.18070256 |
| 177 | Huntingtons disease_Homo sapiens_hsa05016 | 0.15253129 |
| 178 | Lysine degradation_Homo sapiens_hsa00310 | 0.15141441 |
| 179 | Base excision repair_Homo sapiens_hsa03410 | 0.14719730 |
| 180 | RNA degradation_Homo sapiens_hsa03018 | 0.14507227 |
| 181 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.12241495 |
| 182 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.10146691 |

